| Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary Disease (NCT01471587) | Royal Brompton & Harefield NHS Foundation Trust | 2011-12-01 |
| Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients (NCT01526642) | University Hospital, Rouen | 2011-12-01 |
| Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease (NCT02661321) | VA Puget Sound Health Care System | 2011-12-01 |
| Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in Taiwan (NCT01724684) | National Taiwan University Hospital | 2011-12-01 |
| Respiratory Physiology Under High Flow Therapy (NCT01509703) | Institut für Pneumologie Hagen Ambrock eV | 2011-12-01 |
| Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome (NCT01427673) | United States Air Force | 2011-12-01 |
| A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (NCT01448850) | MedImmune LLC | 2011-11-01 |
| Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients (NCT01470274) | Norwegian University of Science and Technology | 2011-11-01 |
| Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching (NCT01494896) | University of Florida | 2011-11-01 |
| Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China (NCT01455129) | The First Affiliated Hospital of Guangzhou Medical University | 2011-11-01 |
| A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01475292) | Respivert Ltd | 2011-11-01 |
| Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2 (NCT01624792) | Texas A&M University | 2011-10-25 |
| The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01490125) | Novartis Pharmaceuticals | 2011-10-01 |
| Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD (NCT01520376) | Nestor Soler Porcar, MD, PhD | 2011-10-01 |
| Effects of Inspiratory Muscle Training on Dyspnea in Subjects With Chronic Obstructive Pulmonary Disease (NCT01545011) | University Hospital, Brest | 2011-10-01 |
| Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct (NCT01426893) | AstraZeneca | 2011-10-01 |
| Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (NCT02257463) | Mansoura University | 2011-10-01 |
| COPE With COPD Trial (NCT02343055) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-10-01 |
| Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (NCT01423227) | La Trobe University | 2011-10-01 |
| Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD) (NCT01577329) | University of Michigan | 2011-10-01 |
| Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population (NCT01619098) | Alison Galbraith | 2011-10-01 |
| Study of Use of CTC in NSCLC (NCT01990651) | University of Virginia | 2011-09-01 |
| Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease (NCT02284932) | Laval University | 2011-09-01 |
| Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01437397) | AstraZeneca | 2011-09-01 |
| Effects of IPV Assessed With Functional Imaging (NCT01671540) | University Hospital, Antwerp | 2011-09-01 |
| Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF) (NCT01424137) | Orion Corporation, Orion Pharma | 2011-09-01 |
| Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients (NCT01382368) | Rabin Medical Center | 2011-09-01 |
| A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) (NCT01351792) | Chiesi Farmaceutici S.p.A. | 2011-09-01 |
| The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV (NCT01478646) | Schön Klinik Berchtesgadener Land | 2011-08-01 |
| Effects of an Inpatient Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease (COPD) III/IV (NCT01418768) | Schön Klinik Berchtesgadener Land | 2011-08-01 |
| Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease (NCT01949181) | Hopital Foch | 2011-08-01 |
| Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01424098) | Roger Goldstein | 2011-08-01 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study (NCT01426009) | Sunovion Respiratory Development Inc. | 2011-08-01 |
| Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD (NCT01393145) | Ache Laboratorios Farmaceuticos S.A. | 2011-08-01 |
| Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation (NCT01750489) | University Medical Center Goettingen | 2011-08-01 |
| Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease (NCT01369810) | AstraZeneca | 2011-07-01 |
| Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease (NCT01372462) | Breathe Technologies, Inc. | 2011-07-01 |
| Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease (NCT01391559) | Dartmouth-Hitchcock Medical Center | 2011-07-01 |
| Physiological and Clinical Changes in NHF Therapy (NCT02504814) | University of Leipzig | 2011-06-01 |
| Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients (NCT01556139) | Fondazione Salvatore Maugeri | 2011-06-01 |
| PT003 MDI Dose Confirmation Study (NCT01349816) | Pearl Therapeutics, Inc. | 2011-06-01 |
| Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients (NCT01376830) | Imperial College London | 2011-06-01 |
| Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD) (NCT01527773) | University of Zurich | 2011-05-01 |
| Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) (NCT01329029) | AstraZeneca | 2011-05-01 |
| Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece (NCT02187926) | AstraZeneca | 2011-05-01 |
| Trial of an Internet-based Platform for Managing Chronic Diseases at a Distance (NCT01342263) | Simon Fraser University | 2011-05-01 |
| PT003 MDI Cardiovascular Safety Study (NCT01349803) | Pearl Therapeutics, Inc. | 2011-05-01 |
| Chest Wall Muscle Stretching and Acute Effects in Chronic Obstructive Pulmonary Disease (NCT01826669) | Universidade Federal de Pernambuco | 2011-05-01 |
| Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects (NCT01354782) | AstraZeneca | 2011-05-01 |
| PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01350128) | Pearl Therapeutics, Inc. | 2011-05-01 |
| Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01380405) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2011-05-01 |
| A Study in Patients With Chronic Obstructive Pulmonary Disease (NCT01245569) | Chiesi Farmaceutici S.p.A. | 2011-04-12 |
| Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease (NCT01318174) | Sykehuset Innlandet HF | 2011-04-01 |
| Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting (NCT01366469) | Emory University | 2011-04-01 |
| A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations (NCT01337661) | MedImmune LLC | 2011-04-01 |
| Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162 (NCT01348555) | Pierre Fabre Medicament | 2011-04-01 |
| Physical Activity Coaching in Chronic Obstructive Pulmonary Disease (COPD) (NCT01349608) | Mayo Clinic | 2011-04-01 |
| Role of Fibrocytes in Chronic Obstructive Pulmonary Disease (NCT01196832) | University Hospital, Bordeaux | 2011-03-11 |
| Identification and Dynamics With Cerebral Functional Magnetic Resonance Imaging (NCT01331070) | Assistance Publique - Hôpitaux de Paris | 2011-03-01 |
| Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective Study (NCT01293890) | KU Leuven | 2011-03-01 |
| A Novel Unidirectional Face Mask During NPPV in COPD Patients (NCT00972868) | Massachusetts General Hospital | 2011-03-01 |
| Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease (NCT01335672) | London School of Hygiene and Tropical Medicine | 2011-03-01 |
| Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01295359) | Universidade Federal de Sao Carlos | 2011-03-01 |
| Effectiveness of Incorporating Tai Chi in Pulmonary Rehabilitation Program for Chronic Obstructive Pulmonary Disease Patients in Primary Health Care (NCT01259245) | Kwong Wah Hospital | 2011-03-01 |
| Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy (NCT01819298) | Far Eastern Memorial Hospital | 2011-03-01 |
| Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities (NCT01325948) | AstraZeneca | 2011-03-01 |
| Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation (NCT01332097) | Mereo BioPharma | 2011-03-01 |
| A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease (NCT01322594) | MedImmune LLC | 2011-03-01 |
| Adjusting to Chronic Conditions Using Education, Support, and Skills (NCT01149772) | VA Office of Research and Development | 2011-02-01 |
| Reliability, Sensitivity and Validity of the 6 Minute Step Test in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01298661) | Universidade Federal de Sao Carlos | 2011-02-01 |
| Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01592656) | FLUIDDA nv | 2011-02-01 |
| A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease (NCT01268072) | MedImmune LLC | 2011-02-01 |
| Social Work Intervention Focused on Transitions (NCT02232126) | University of Southern California | 2011-02-01 |
| Combined Illness Management and Psychotherapy in Treating Depressed Elders (NCT01337726) | University of Iowa | 2011-02-01 |
| Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 (NCT01333904) | Pulmatrix Inc. | 2011-02-01 |
| Myotrace: An Evaluation of a Novel Critical Illness Monitoring System (NCT01361451) | Guy's and St Thomas' NHS Foundation Trust | 2011-01-01 |
| The Lung Attack Alert Study (NCT01107613) | University of Alberta | 2011-01-01 |
| Metformin in Chronic Obstructive Pulmonary Disease (NCT01247870) | St George's, University of London | 2011-01-01 |
| ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment) (NCT01475045) | Elpen Pharmaceutical Co. Inc. | 2011-01-01 |
| Effects of Non-invasive Ventilation on Rehabilitation Outcome in COPD-patients (NCT01384981) | Schön Klinik Berchtesgadener Land | 2011-01-01 |
| AZD2115 Single Ascending Dose Study (NCT01283984) | AstraZeneca | 2011-01-01 |
| A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD (NCT01270594) | University of Wisconsin, Madison | 2011-01-01 |
| Novel Endpoints in Cough Challenge Testing (NCT01566968) | Manchester University NHS Foundation Trust | 2011-01-01 |
| Patient -Ventilator Interaction in Chronic Respiratory Failure (NCT01371149) | Michelle Ramsay | 2011-01-01 |
| Characterisation of People With COPD (NCT01263340) | National Services for Health Improvement Ltd | 2010-12-01 |
| Study of COPD Subgroups and Biomarkers (NCT01969344) | University of North Carolina, Chapel Hill | 2010-11-01 |
| Withdrawal of Non-invasive Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure (NCT01523470) | United Christian Hospital | 2010-11-01 |
| Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD) (NCT01096303) | The University of Texas Health Science Center, Houston | 2010-11-01 |
| To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart (NCT01222442) | AstraZeneca | 2010-11-01 |
| Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease (NCT01465906) | Shanghai Zhongshan Hospital | 2010-11-01 |
| Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients (NCT01402297) | Medical University of Lodz | 2010-10-01 |
| Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) (NCT01153321) | AstraZeneca | 2010-10-01 |
| AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) (NCT01215279) | AstraZeneca | 2010-10-01 |
| Pathophysiological Mechanisms of Dyspnea and Activity-limitation in Mild Chronic Obstructive Pulmonary Disease (COPD) (NCT00975403) | Queen's University | 2010-10-01 |
| Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry (NCT01576068) | Col·legi de Farmacèutics de la Província de Barcelona | 2010-10-01 |
| The International Nocturnal Oxygen (INOX) Trial (NCT01044628) | Laval University | 2010-10-01 |
| Impact of Muscle Afferent Feedback During Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01522729) | Laval University | 2010-10-01 |
| Clinical Trial Assessing the Value of an Antibiotic Protocol Guided by Serum Procalcitonin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Intensive Care (NCT02521636) | University Hospital, Caen | 2010-10-01 |
| A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD) (NCT01219946) | AstraZeneca | 2010-10-01 |
| Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD) (NCT00864994) | Top Institute Pharma | 2010-09-01 |